Target intelligence / Profile preview

Ribosomal protein L15 pseudogene 17 (RPL15P17)

Target: RPL15P17
Molecular classification: Other

Overview

Ribosomal protein L15 pseudogene 17 (RPL15P17) is a predicted human pseudogene derived from the ribosomal protein L15 gene. It is classified as a pseudogene, meaning it does not encode a functional protein product and is not known to have any established biological function or disease association. Pseudogenes are remnants of genes that have lost the ability to code for a protein, often due to mutations or lack of regulatory elements, and are not considered therapeutic targets. No pharmacological agents are known to interact with this gene, nor is it considered relevant for drug targeting, biomarker development, or disease pathogenesis.

Other names: RPL15_10_1204RPL15P17

Beyond the preview

Go deeper on Ribosomal protein L15 pseudogene 17 (RPL15P17).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L15 pseudogene 17 (RPL15P17).

Explore the full profile